Old Web
English
Sign In
Acemap
>
authorDetail
>
RuiRong Yuan
RuiRong Yuan
Novartis
Medicine
Cancer
Internal medicine
Oncology
Everolimus
3
Papers
217
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Molecular diagnosis and targeted therapy of a pediatric chronic eosinophilic leukemia patient carrying TPM3-PDGFRB fusion.
2011
Pediatric Blood & Cancer
Zhipeng Li
Rong Yang
Jiangning Zhao
RuiRong Yuan
Quanyi Lu
Qingge Li
William Tse
Show All
Source
Cite
Save
Citations (10)
PILLAR-1: Preliminary Results of a Phase II Study of mTOR Inhibitor Everolimus In Patients with Mantle Cell Lymphoma (MCL) Who Are Refractory or Intolerant to Bortezomib
2010
Blood
Owen A. OConnor
Leslie Popplewell
Jane N. Winter
RuiRong Yuan
Anna Robeva
Helene Cauwel
Quincy Chau
Michael Wang
Show All
Source
Cite
Save
Citations (14)
Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy
2009
Journal of Hematology & Oncology
RuiRong Yuan
Andrea Kay
William Berg
David Lebwohl
Show All
Source
Cite
Save
Citations (193)
1